Mechanisms of Severe Mortality-Associated Bacterial Co-infections Following Influenza Virus Infection

被引:82
作者
Jia, Leili [1 ]
Xie, Jing [1 ]
Zhao, Jiangyun [1 ]
Cao, Dekang [2 ]
Liang, Yuan [1 ]
Hou, Xuexin [3 ]
Wang, Ligui [1 ]
Li, Zhenjun [3 ]
机构
[1] Chinese Peoples Liberat Army, Inst Dis Control & Prevent, Beijing, Peoples R China
[2] Chinese Peoples Armed Police Forces, Ctr Dis Control & Prevent, Beijing, Peoples R China
[3] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China
来源
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY | 2017年 / 7卷
基金
中国国家自然科学基金;
关键词
co-infection; influenza; bacteria; resumption of function; tolerance; mortality; RESPIRATORY-TRACT INFECTION; ACTIVATING-FACTOR RECEPTOR; STREPTOCOCCUS-PNEUMONIAE; STAPHYLOCOCCUS-AUREUS; A VIRUS; I INTERFERONS; PNEUMOCOCCAL INFECTION; MENINGOCOCCAL DISEASE; ALVEOLAR MACROPHAGES; PANDEMIC INFLUENZA;
D O I
10.3389/fcimb.2017.00338
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Influenza virus infection remains one of the largest disease burdens on humans. Influenza-associated bacterial co-infections contribute to severe disease and mortality during pandemic and seasonal influenza episodes. The mechanisms of severe morbidity following influenza bacteria co-infections mainly include failure of an antibacterial immune response and pathogen synergy. Moreover, failure to resume function and tolerance might be one of the main reasons for excessive mortality. In this review, recent advances in the study of mechanisms of severe disease, caused by bacterial co-infections following influenza virus pathogenesis, are summarized. Therefore, understanding the synergy between viruses and bacteria will facilitate the design of novel therapeutic approaches to prevent mortality associated with bacterial co-infections.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Analysis of Fungal and Bacterial Co-Infections in Mortality Cases among Hospitalized Patients with COVID-19 in Taipei, Taiwan
    Lu, De-En
    Hung, Shih-Han
    Su, Ying-Shih
    Lee, Wen-Sen
    JOURNAL OF FUNGI, 2022, 8 (01)
  • [42] Replication-Competent Influenza Virus and Respiratory Syncytial Virus Luciferase Reporter Strains Engineered for Co-Infections Identify Antiviral Compounds in Combination Screens
    Yan, Dan
    Weisshaar, Marco
    Lamb, Kristen
    Chung, Hokyung K.
    Lin, Michael Z.
    Plemper, Richard K.
    BIOCHEMISTRY, 2015, 54 (36) : 5589 - 5604
  • [43] A Narrative Review of Key Risk Factors for Severe Illness Following SARS-CoV-2, Influenza Virus, and Respiratory Syncytial Virus Infection
    Branche, Angela
    Ramesh, Mayur
    Francis, Beverly
    INFECTIOUS DISEASES AND THERAPY, 2025, 14 (SUPPL1) : 39 - 61
  • [44] Mortality risk factors in children with severe influenza virus infection admitted to the pediatric intensive care unit
    Shi, Tingting
    Nie, Zhiqiang
    Huang, Li
    Fan, Huifeng
    Lu, Gen
    Yang, Diyuan
    Zhang, Dongwei
    MEDICINE, 2019, 98 (35) : e16861
  • [45] Increased virus dissemination leads to enhanced lung injury but not inflammation during influenza-associated secondary bacterial infection
    Smith, Amanda P.
    Lane, Lindey C.
    Zuniga, Ivan Ramirez
    Moquin, David M.
    Vogel, Peter
    Smith, Amber M.
    FEMS MICROBES, 2022, 3
  • [46] Evaluation of respiratory tract bacterial co-infections in SARS-CoV-2 patients with mild or asymptomatic infection in Lagos, Nigeria
    Olabisi Flora Davies-Bolorunduro
    Muinah Adenike Fowora
    Olufemi Samuel Amoo
    Esther Adeniji
    Kazeem Adewale Osuolale
    Oluwatobi Oladele
    Tochukwu Ifeanyi Onuigbo
    Josephine Chioma Obi
    Joy Oraegbu
    Oluwatobi Ogundepo
    Rahaman Ademolu Ahmed
    Olagoke AbdulRazaq Usman
    Bosede Ganiyat Iyapo
    Adedamola Adejuwon Dada
    Ngozi Onyia
    Richard Adebayo Adegbola
    Rosemary Ajuma Audu
    Babatunde Lawal Salako
    Bulletin of the National Research Centre, 46 (1)
  • [47] Unexpectedly Higher Morbidity and Mortality of Hospitalized Elderly Patients Associated with Rhinovirus Compared with Influenza Virus Respiratory Tract Infection
    Hung, Ivan F. N.
    Zhang, Anna Jinxia
    To, Kelvin K. W.
    Chan, Jasper F. W.
    Zhu, Shawn H. S.
    Zhang, Ricky
    Chan, Tuen-Ching
    Chan, Kwok-Hung
    Yuen, Kwok-Yung
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (02)
  • [48] Biomarkers associated with vaccine-associated enhanced respiratory disease following influenza A virus infection in swine
    Brand, Meghan Wymore
    Souza, Carine K.
    Gauger, Phillip
    Arruda, Bailey
    Baker, Amy L. Vincent
    VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2024, 273
  • [49] Can procalcitonin help identify associated bacterial infection in patients with severe influenza pneumonia? A multicentre study
    Cuquemelle, E.
    Soulis, F.
    Villers, D.
    Roche-Campo, F.
    Somohano, C. Ara
    Fartoukh, M.
    Kouatchet, A.
    Mourvillier, B.
    Dellamonica, J.
    Picard, W.
    Schmidt, M.
    Boulain, T.
    Brun-Buisson, C.
    INTENSIVE CARE MEDICINE, 2011, 37 (05) : 796 - 800
  • [50] Combination of procalcitonin and C-reactive protein levels in the early diagnosis of bacterial co-infections in children with H1N1 influenza
    Li, Zhihao
    He, Liya
    Li, Shuhua
    He, Waner
    Zha, Caihui
    Ou, Wanxing
    Hou, Qiaozhen
    Wang, Weiying
    Sun, Xin
    Liang, Huiying
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2019, 13 (02) : 184 - 190